[208 Pages Report] The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.  

On the basis of type, the market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest share in 2018. 

By application, the market is categorized into implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the market. 

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198160556 

The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomes in developing countries. 

Based on the end user, the market is segmented into dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes. In 2018, the dental implant and prosthetic manufacturers segment accounted for the largest of the market. 

The prominent players in the global market are Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US).